Impact of inflammation and the immune system on hepatocellular carcinoma recurrence after hepatectomy
Cancer Medicine · 2024-02 · 13 (4)
DOI: 10.1002/cam4.7018 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Medicine, online erschienen am 08.03.2024. Verfasst von Sha She und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Interdisciplinary Innovative Talents Foundation from Renmin Hospital of Wuhan University.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer‐related death worldwide. Hepatectomy remains the first‐line treatment for patients with resectable HCC. However, the reported recurrence rate of HCC at 5 years after surgery is between 50% and 70%. Tumor‐related factors, including tumor size, number and differentiation, and underlying liver disease are well‐known risk factors for recurrence after treatment. In addition to tumor‐related factors, ever‐increasing amounts of studies are finding that the tumor microenvironment also plays an important role in the recurrence of HCC, including systemic inflammatory response and immune regulation. Based on this, some inflammatory and immune markers were used in predicting postoperative cancer recurrence. These include neutrophil‐to‐lymphocyte ratio, platelet‐to‐lymphocyte ratio, cytotoxic T cells, and regulatory T cells, among others. In this review, we summarized the inflammatory and immune markers that affect recurrence after HCC resection in order to provide direction for adjuvant therapy after HCC resection and ultimately achieve the goal of reducing recurrence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China.
- Department of Hepatobiliary surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei Province, China.
ORCID-Profile: Sha She
Förderung
- National Natural Science Foundation of China
- Interdisciplinary Innovative Talents Foundation from Renmin Hospital of Wuhan University
Zitieren
APA
She, S., Shi, J., Zhu, J., Yang, F., Yu, J., & Dai, K. (2024). Impact of inflammation and the immune system on hepatocellular carcinoma recurrence after hepatectomy. Cancer Medicine, 13(4). https://doi.org/10.1002/cam4.7018
Vancouver
She S, Shi J, Zhu J, Yang F, Yu J, Dai K. Impact of inflammation and the immune system on hepatocellular carcinoma recurrence after hepatectomy. Cancer Medicine. 2024;13(4). doi:10.1002/cam4.7018
BibTeX
@article{She2024,
author = {She, Sha and Shi, Jinzhi and Zhu, Jiling and Yang, Fan and Yu, Jia and Dai, Kai},
title = {Impact of inflammation and the immune system on hepatocellular carcinoma recurrence after hepatectomy},
journal = {Cancer Medicine},
year = {2024},
volume = {13},
number = {4},
doi = {10.1002/cam4.7018}
}
EUVIMED